EpiCept Corporation

Industry

  • Pharmaceuticals
    • Specialty Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Transdermal
      • Topical Delivery
  • Biotechnology

Other Names/Subsidiaries

  • Maxim Pharmaceuticals
See more in Biomedtracker

Latest on EpiCept Corporation

Scrip

Tech Transfer Roundup: Universities And Biotechs Continue To Look For Ways To Combat COVID-19

 
• By Joseph Haas

Below is Scrip’s regular roundup, including information from Strategic Transactions , of recent technology transfer agreements and collaborations between companies and academic or other research inst

Scrip

Tech Transfer Roundup: Be Cool Therapeutics Sees Potential In Mimicking Hibernation

 
• By Joseph Haas

Below is Scrip’s regular roundup, including information from Strategic Transactions , of recent technology transfer agreements and collaborations between companies and academic or other research inst

Scrip

Deal Watch: Alnylam/Dicerna Pact Addresses IP Questions Around Primary Hyperoxaluria Programs

 
• By Joseph Haas, Ian Haydock, and Jung Won Shin

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Alnylam And Dicerna Team Up

In Vivo

Deals Shaping the Medical Industry, August 2017

 
• By Beth Allan, Deanna Kamienski, Maureen Riordan, Amanda Micklus, and Steven Muntner

IN VITRO DIAGNOSTICS Mergers & Acquisitions Abbott Laboratories Inc. Alere Inc. Quidel Corp. Quidel Corp. is acquiring Alere 's Triage MeterPro cardiovascular and toxicology assets and the Tri